نتائج البحث - "SERUM ALANINE AMINOTRANSFERASE"

1

Incidence of Hepatocellular Carcinoma and Decompensated Liver Cirrhosis and Prognostic Accuracy of the PAGE-B HCC Risk Score in a Low Endemic Hepatitis B Virus Infected Population

المؤلفون: Signe Bollerup, Frederik Engsig, Sofie Hallager, Amanda Mocroft, Birgit T Roege, Peer B Christensen, Alex L Laursen, Henrik Krarup, Mette R Clausen, Peter Thielsen, Lone G Madsen, Lars Noerregaard, Toke S Barfod, Ulla Balslev, Britta Tarp, Jesper B Hansen, Lone H Mygind, Jan Gerstoft, Nina Weis

المصدر: Bollerup, S, Engsig, F, Hallager, S, Mocroft, A, Roege, B T, Christensen, P B, Laursen, A L, Krarup, H, Clausen, M R, Thielsen, P, Madsen, L G, Noerregaard, L, Barfod, T S, Balslev, U, Tarp, B, Hansen, J B, Mygind, L H, Gerstoft, J & Weis, N 2022, ' Incidence of Hepatocellular Carcinoma and Decompensated Liver Cirrhosis and Prognostic Accuracy of the PAGE-B HCC Risk Score in a Low Endemic Hepatitis B Virus Infected Population ', Journal of Hepatocellular Carcinoma, vol. 9, pp. 1093-1104 . https://doi.org/10.2147/JHC.S372571Test

مصطلحات موضوعية: ANTIVIRAL TREATMENT, OUTCOMES, SERUM ALANINE AMINOTRANSFERASE, viral hepatitis, morbidity, PROGRESSION, HBEAG, DISEASE, PREDICTS, UPPER LIMITS, MANAGEMENT, Scandinavia, CAUCASIANS, hepatitis B virus, nationwide, Journal of Hepatocellular Carcinoma

وصف الملف: text/html; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a297bc42293ee29a254b2432bd5b40f8Test
https://pubmed.ncbi.nlm.nih.gov/36281336Test

2

Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients

المؤلفون: Yueyong Zhu, Meng-Xin Lin, Yu-Rui Liu, Na-Ling Kang, Zu-Xiong Huang, Jie-Min Zhang, Da-Wu Zeng, Xu-Dong Chen

المصدر: World Journal of Gastroenterology

مصطلحات موضوعية: Adult, Liver Cirrhosis, Male, Hepatitis B virus, HBsAg, medicine.medical_specialty, Cirrhosis, Liver fibrosis, medicine.disease_cause, Gastroenterology, 03 medical and health sciences, Serum ceruloplasmin, Hepatitis B, Chronic, 0302 clinical medicine, Retrospective Study, Internal medicine, medicine, Humans, Platelet, Retrospective Studies, Receiver operating characteristic, biology, business.industry, Noninvasive model, Ceruloplasmin, Alanine Transaminase, General Medicine, Middle Aged, medicine.disease, Receiver-operating characteristic, Chronic hepatitis B infection, Serum alanine aminotransferase, Liver, ROC Curve, 030220 oncology & carcinogenesis, biology.protein, Female, 030211 gastroenterology & hepatology, business, Biomarkers

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::728d957a3db7b1fbd97fc3676d8d1b75Test
https://doi.org/10.3748/wjg.v26.i27.3952Test

3

Non-alcoholic fatty liver disease: A patient guideline

المؤلفون: Shira Zelber-Sagi, Rebecca Dorner, Giulio Marchesini, Marko Korenjak, Christos Lionis, Jeffrey V. Lazarus, Sven Francque, Achim Kautz, Luca Busetto, José Willemse, G. Koek, Dror Dicker, Kate Hallsworth, Shlomo Vinker, Gema Frühbeck, Euan Woodward, Mehmet Ungan, Juan M. Mendive, Martine Walmsley

المساهمون: Francque, Sven M, Marchesini, Giulio, Kautz, Achim, Walmsley, Martine, Dorner, Rebecca, Lazarus, Jeffrey V, Zelber-Sagi, Shira, Hallsworth, Kate, Busetto, Luca, Frühbeck, Gema, Dicker, Dror, Woodward, Euan, Korenjak, Marko, Willemse, José, Koek, Gerardus H, Vinker, Shlomo, Ungan, Mehmet, Mendive, Juan M, Lionis, Christos, Interne Geneeskunde, MUMC+: MA Maag Darm Lever (9), RS: NUTRIM - R2 - Liver and digestive health

المصدر: JHEP Reports
JHEP Reports, Vol 3, Iss 5, Pp 100322-(2021)
JHEP Reports, 3(5):100322. Elsevier BV

مصطلحات موضوعية: NASH, non-alcoholic steatohepatiti, Y GASTRIC BYPASS, Disease, RC799-869, PLACEBO-CONTROLLED TRIAL, LIFE-STYLE MODIFICATION, cardiovascular disease, LDL, low-density lipoprotein, HEPATOCELLULAR-CARCINOMA, non-invasive test, T2D, GLP-1 RAs, glucagon-like receptor 1 agonists, European Association for the Study of Obesity, HCC, Gastroenterology, NASH, specific, Diseases of the digestive system. Gastroenterology, CAP, controlled attenuation parameter, CT, computed tomography, FXR, ASH, alcoholic steatohepatitis, GP, non-alcoholic steatohepatitis, GLP-1 RAs, glucagon-like receptor 1 agonist, LDL, low-density lipoproteins, medicine.medical_specialty, HDL, achievable, NASH, non-alcoholic steatohepatitis, T2D, type 2 diabetes, high-density lipoprotein, CVD, cardiovascular disease, LDL, Patient Guideline, Quality of life (healthcare), FXR, farnesoid X receptor, NAFLD, low-density lipoproteins, GP, general practitioner, NAFL, non-alcoholic fatty liver, FIB-4, fibrosis-4 index, Intensive care medicine, computed tomography, Guideline, medicine.disease, T1D, type 1 diabete, digestive system diseases, NIT, Human medicine, farnesoid X receptor, type 1 diabetes, BMI, body mass index, EASL, European Association for the Study of the Liver, Placebo-controlled study, Chronic liver disease, GLP-1 RAs, QUALITY-OF-LIFE, alcoholic steatohepatitis, European Association for the Study of Diabetes, EASD, European Association for the Study of Diabetes, Immunology and Allergy, magnetic resonance imaging, NASH Clinical Research Network, ALD, alcohol-related or alcoholic liver disease, Disease management (health), glucagon-like receptor 1 agonists, EASO, European Association for the Study of Obesity, NASH CRN, NASH Clinical Research Network, ASH, alcoholic steatohepatiti, Fatty liver, timely, hepatocellular carcinoma, CVD, magnetic resonance elastography, MRE, NAFL, FIB-4, non-alcoholic fatty liver, type 2 diabetes, T1D, type 1 diabetes, CAP, controlled attenuation parameter, CT, European Association for the Study of the Liver, MRI, fibrosis-4 index, NAFLD, non-alcoholic fatty liver disease, EASD, HDL, high-density lipoprotein, UNITED-STATES, ASH, body mass index, EASL, measurable, BMI, NIT, non-invasive test, Internal Medicine, medicine, NASH CRN, HEPATIC STEATOSIS, HCC, hepatocellular carcinoma, MRE, magnetic resonance elastography, MRI, magnetic resonance imaging, SMART, specific, measurable, achievable, relevant, timely, Disease burden, BARIATRIC SURGERY, Hepatology, SMART, business.industry, SERUM ALANINE AMINOTRANSFERASE, non-alcoholic fatty liver disease, PHYSICAL-ACTIVITY, alcohol-related or alcoholic liver disease, EASD, European Association for the Study of Diabete, EASO, ALD, general practitioner, relevant, T1D, business